AZ and Luye Pharma complete agreement for Seroquel
28 June 2018 13:30 BST Agreement with Luye Pharma Group for rights to Seroquel and Seroquel XR in the UK, China and other international markets completed AstraZeneca today completed an agreement with Luye Pharma Group, Ltd. (Luye Pharma) for the sale and licence of the rights to Seroquel and Seroquel XR in the UK, China and other international markets, including Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia and South Africa. Under the terms of the agreement, AstraZeneca has received a payment of $260m from Luye Pharma as part of the total $538m